Total Payments
$490.36
2020 Payments
$45.02
Companies
12
Transactions
30
Medicare Patients
7,997
Medicare Billing
$625,532
Payment Breakdown by Category
Food & Beverage$490.36 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $490.36 | 30 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $152.13 | 10 | $0 (2018) |
| Celgene Corporation | $80.48 | 5 | $0 (2019) |
| Janssen Biotech, Inc. | $68.45 | 4 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $40.84 | 2 | $0 (2018) |
| EISAI INC. | $37.44 | 2 | $0 (2019) |
| Jazz Pharmaceuticals Inc. | $24.09 | 1 | $0 (2020) |
| Puma Biotechnology, Inc. | $18.32 | 1 | $0 (2019) |
| ARIAD Pharmaceuticals, Inc. | $15.90 | 1 | $0 (2017) |
| Seattle Genetics, Inc. | $13.71 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $13.52 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $45.02 | 2 | Jazz Pharmaceuticals Inc. ($24.09) |
| 2019 | $120.24 | 8 | Janssen Biotech, Inc. ($31.10) |
| 2018 | $156.53 | 10 | Bayer HealthCare Pharmaceuticals Inc. ($70.75) |
| 2017 | $168.57 | 10 | Bayer HealthCare Pharmaceuticals Inc. ($81.38) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/28/2020 | Jazz Pharmaceuticals Inc. | VYXEOS (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 02/13/2020 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Oncology | ||||||
| 10/09/2019 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2019 | Janssen Biotech, Inc. | Balversa (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Oncology | ||||||
| 09/26/2019 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Oncology | ||||||
| 08/02/2019 | Celgene Corporation | Abraxane (Drug) | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: Oncology | ||||||
| 07/17/2019 | Janssen Biotech, Inc. | Balversa (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Oncology | ||||||
| 03/26/2019 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $14.99 | General |
| Category: Oncology | ||||||
| 03/04/2019 | Celgene Corporation | Abraxane (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Oncology | ||||||
| 01/29/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $13.52 | General |
| Category: Oncology | ||||||
| 12/20/2018 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Oncology | ||||||
| 11/15/2018 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Oncology | ||||||
| 10/11/2018 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Oncology | ||||||
| 09/20/2018 | Celgene Corporation | Abraxane (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Oncology | ||||||
| 08/30/2018 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug), SANDOSTATIN LAR | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: ONCOLOGY | ||||||
| 07/12/2018 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Oncology | ||||||
| 05/31/2018 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Oncology | ||||||
| 04/12/2018 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Oncology | ||||||
| 04/04/2018 | INSYS Therapeutics Inc | SYNDROS (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Chemotherapy-Induced Nausea and Vomiting | ||||||
| 01/11/2018 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug), SANDOSTATIN LAR | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: ONCOLOGY | ||||||
| 10/19/2017 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug), Nexavar | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: Oncology | ||||||
| 07/27/2017 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $22.45 | General |
| Category: Oncology | ||||||
| 06/01/2017 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Hematology / Oncology | ||||||
| 05/18/2017 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: Oncology | ||||||
| 05/09/2017 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug), Nexavar | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 1,901 | 1,954 | $1.0M | $159,891 |
| 2022 | 36 | 2,099 | 2,174 | $1.0M | $167,062 |
| 2021 | 38 | 2,195 | 2,257 | $898,121 | $164,277 |
| 2020 | 38 | 1,802 | 1,864 | $759,639 | $134,303 |
Total Patients
7,997
Total Services
8,249
Medicare Billing
$625,532
Procedure Codes
180
All Medicare Procedures & Services
180 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 73721 | Mri scan of leg joint without contrast | Office | 2023 | 265 | 274 | $280,769 | $42,100 | 15.0% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2023 | 249 | 250 | $270,660 | $36,092 | 13.3% |
| 73221 | Mri scan of arm joint without contrast | Office | 2023 | 132 | 137 | $139,936 | $21,393 | 15.3% |
| 72141 | Mri scan of upper spinal canal without contrast | Office | 2023 | 61 | 61 | $59,360 | $8,141 | 13.7% |
| 70450 | Ct scan head or brain without contrast | Facility | 2023 | 155 | 166 | $21,248 | $5,047 | 23.8% |
| 73718 | Mri scan of leg without contrast | Office | 2023 | 28 | 29 | $25,418 | $4,687 | 18.4% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Facility | 2023 | 61 | 62 | $19,650 | $4,274 | 21.8% |
| 72158 | Mri scan of lower spinal canal before and after contrast | Office | 2023 | 14 | 14 | $32,200 | $3,737 | 11.6% |
| 71250 | Ct scan of chest without contrast | Facility | 2023 | 75 | 77 | $17,238 | $3,199 | 18.6% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Facility | 2023 | 38 | 39 | $11,205 | $2,638 | 23.5% |
| 72146 | Mri scan of middle spinal canal without contrast | Office | 2023 | 22 | 22 | $20,652 | $2,562 | 12.4% |
| 72125 | Ct scan of upper spine without contrast | Facility | 2023 | 60 | 62 | $10,864 | $2,240 | 20.6% |
| 72195 | Mri scan of pelvis without contrast | Office | 2023 | 12 | 12 | $11,438 | $2,047 | 17.9% |
| 72148 | Mri scan of lower spinal canal without contrast | Facility | 2023 | 29 | 29 | $8,102 | $1,694 | 20.9% |
| 70551 | Mri scan of brain without contrast | Facility | 2023 | 31 | 31 | $7,870 | $1,558 | 19.8% |
| 70553 | Mri scan of brain before and after contrast | Facility | 2023 | 16 | 16 | $6,756 | $1,456 | 21.6% |
| 71275 | Ct scan of blood vessels of chest with contrast | Facility | 2023 | 21 | 21 | $6,048 | $1,433 | 23.7% |
| 71260 | Ct scan of chest with contrast | Facility | 2023 | 27 | 27 | $6,030 | $1,196 | 19.8% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Facility | 2023 | 22 | 22 | $4,280 | $1,182 | 27.6% |
| 74183 | Mri scan of abdomen before and after contrast | Facility | 2023 | 11 | 11 | $4,372 | $957.77 | 21.9% |
| 77067 | Screening mammography | Office | 2023 | 25 | 25 | $3,000 | $948.50 | 31.6% |
| 70496 | Ct scan of blood vessels of head with contrast | Facility | 2023 | 13 | 13 | $3,432 | $895.53 | 26.1% |
| 72141 | Mri scan of upper spinal canal without contrast | Facility | 2023 | 17 | 17 | $5,410 | $884.67 | 16.4% |
| 70498 | Ct scan of blood vessels of neck with contrast | Facility | 2023 | 13 | 13 | $3,419 | $864.46 | 25.3% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 25 | 25 | $4,350 | $858.31 | 19.7% |
About Dr. Justin Blum, M.D
Dr. Justin Blum, M.D is a Diagnostic Radiology healthcare provider based in Upland, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760429898.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Justin Blum, M.D has received a total of $490.36 in payments from pharmaceutical and medical device companies, with $45.02 received in 2020. These payments were reported across 30 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($490.36).
As a Medicare-enrolled provider, Blum has provided services to 7,997 Medicare beneficiaries, totaling 8,249 services with total Medicare billing of $625,532. Data is available for 4 years (2020–2023), covering 180 distinct procedure/service records.
Ad
Practice Information
- Specialty Diagnostic Radiology
- Location Upland, PA
- Active Since 05/31/2006
- Last Updated 03/17/2008
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1760429898
Products in Payments
- Xofigo (Drug) $105.49
- Stivarga (Drug) $46.64
- Abraxane (Drug) $45.35
- AFINITOR (Drug) $40.84
- Lenvima (Drug) $37.44
- DARZALEX (Biological) $37.35
- Balversa (Drug) $31.10
- VYXEOS (Drug) $24.09
- Revlimid (Drug) $18.75
- Nerlynx (Drug) $18.32
- Pomalyst (Drug) $16.38
- Iclusig (Drug) $15.90
- ADCETRIS (Biological) $13.71
- OPDIVO (Biological) $13.52
- SYNDROS (Drug) $13.25
- ZEJULA (Drug) $12.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Upland
Lorna Blum, M.d, M.D
Diagnostic Radiology — Payments: $978,753
Diagnostic Radiology $978,753
John Hiehle, Md, MD
Diagnostic Radiology — Payments: $1,310
Diagnostic Radiology $1,310
Khozaim Nakhoda, Md, MD
Diagnostic Radiology — Payments: $1,098
Diagnostic Radiology $1,098
Gregory Schwartzman, Md, MD
Diagnostic Radiology — Payments: $952.66
Diagnostic Radiology $952.66
Dr. David Dang, M.d, M.D
Diagnostic Radiology — Payments: $599.73
Diagnostic Radiology $599.73
Dr. Damon Soeiro, Md, MD
Diagnostic Radiology — Payments: $515.92
Diagnostic Radiology $515.92